. Light microscope photograph of TB-stained section from a bone conduction chamber grafted with the novel biomaterial (DTG). The photograph shows newly formed bone (*) in direct contact with the remaining monoclinic DCPD crystals (+). The interface between the biomaterial and the bone tissue is rough and a Howship´s lacuna can be observed (arrow) (original magnification x40). Fig. 9 . Light microscope photograph of TB-stained section from a bone conduction chamber grafted with the novel biomaterial (DTG). The photograph shows newly formed bone growing in a lamellar orientation (arrow heads) in direct contact with the remaining monoclinic DCPD crystals (arrow) (original magnification x40). All data presented are mean values (±standard deviation). * Significantly higher than all control groups (p<0.05). BMD: Bone mineral density values. 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Bone regeneration techniques constitute a valid surgical procedure for increasing bone quantity and quality in areas where insufficient bone volume prevents the stabilization of osteointegrated implants. Biomaterials for stimulating osseous regeneration should combine osteogenic, osteoinductive and osteoconductive properties. Besides, they should be resorbed and gradually replaced by newly formed bone (Giannoudis et al. 2005) . The use of several bone substitutes has been described for bone regeneration but so far, only autografts (autologous bone grafts) reunites all the mentioned properties being the most suitable material. However, the limited availability of autografts in intraoral areas and the post-operative morbidity associated with the employment of extraoral grafts forces the physicians to use other biomaterials in bone regeneration (Block & Kent 1997 ).
An alternative to autografts are the allogenic biomaterials (grafts from another individual of the same species), such as human demineralised freeze-dried bone, provided by tissue banks. Unfortunately, there is some controversy regarding the osteoinductive capability of these materials (Schwartz et al. 1998) , besides, they have the risk of immunological rejection and transmission of infections such as HIV and hepatitis that requires special manufacture measurements (Giannoudis et al. 2005) . Currently, only bone morphogenetic proteins (BMP) seem to have osteoinductive properties but their use for dental practice is still in experimental phase (M. Nevins et al. 1996) .
The osteoconductive properties offered by natural bone substitutes from animal origin, such as collagens and bovine hydroxyapatite Bio-Oss® (Geistlich Biomaterials; Wolhusen, Switzerland) overcome some of the autografts' limitations (Von Arx et al. 2001) . For instance, Bio-Oss® chemical composition is very similar to that of human bone hydroxyapatite (HA) since it contains a calcium/phosphate proportion of 1.67 identical to bone HA (Suzuki et al. 2000) . Besides, its mineral matrix contains crystals of c.a. 100 µm diameter presenting morphological and structural properties very similar to those of the human bone (Rosen & Hobbs 2002) . Furthermore, Bio-Oss® rough topography favours osteoblastic anchorage, proliferation and synthesis of bone matrix on its surface (Acil et al. 2000) , and currently is one of the most frequently employed biomaterials in bone regenerative procedures. However, HA based biomaterials are very slowly resorbed in vivo.
Third generation biomaterials are designed with the aim to help the body self healing. One desirable characteristic in bone materials is their ability to be remodeled, i.e. the biomaterial is resorbed by osteoclasts and subsequently replaced by newly formed bone through osteoblastic activity (Schilling et al 2004) . Biomaterials with slow resorption rate, such as HA, interfere with bone growth, while biomaterials with fast resorption rate, such as calcium sulphates, compromise the stability of the surgical site during the healing process (Stavropoulos et al. 2004 , Lieberman et al. 2005 . New biomaterials are designed to have resorption speed that match bone growth rate. It is to be noted that brushite crystals have an in vivo resorption rate similar to human bone growth speed, c.a. 20 µm per day, and this fact can be very important in stabilizing the newly formed bone. (Bohner et al. 2005 (Giannoudis et al. 2005) , and have a higher resorption rate in vivo than HA materials allowing bone formation simultaneously to material resorption (Trisi et al. 2003 , Chow el al. 2003 ).
Mirtchi and Lemaitre introduced in 1987 the first cement made from DCDP and -TCP obtained from the reaction of a base ( -TCP) and an acid (mono-calcium phosphate). The set cement composition presented a mixture of two minerals: -TCP and DCDP (Mirtchi & Lemaitre 1989) . The significance of this cement lays on its capacity to decompose in physiological environments and be resorbed by the body. Investigations performed in this cement showed that DCDP is resorbed up to 3 times faster than HA or -TCP (Chow et al. 2003) . This property seems to prove its feasibility in accelerating the substitution of the biomaterial by newly formed bone. Surprisingly this biomaterial has barely been studied for dental implantology purposes although it has proved to be useflul in orthopaedic applications for stabilizing fractures or filling defects (Bohner et al. 2005 ).
Most investigations that evaluate bone forming capacity of biomaterials are performed in Critical Size Defect models (CSD) (see Fig.1A ). However, in daily clinical practice, bone regeneration is often needed to grow vertically from the surface of the native bone, i.e. a vertical bone augmentation. The evaluation of bone regeneration is better performed with the bone conduction model (Fig.1B) introducing barriers in the bone defect that prevent lateral bone formation and allow bone growth only in the vertical direction , Lundgren et al. 2000 .
The purpose of this study was to evaluate the bone regenerative capacity of a novel brushite/ -TCP pre-set cement in granular form (DTG) and to compare its behaviour with the commercial bovine bone Bio-Oss®. The two biomaterials were implanted in rabbits using a calvaria a titanium cylinder bone conduction model and new bone tissue formation was analyzed 4 weeks after the intervention. 
Materials and Methods
The preparation of the new biomaterial is explained elsewhere (Tamimi et al. 2005 ) but herein is a brief description of the synthesis (Tamimi et al. 2005) . The new biomaterial (DTG) was made from a brushite cement composed of monocalcium phosphate (0.8g) and -TCP (1.4g) that sets in a glycolic acid aqueous solution (1 M) using a powder to liquid ratio of 1.7g/L. The cement was left to set ex vivo into a hard material that was milled with a mortar and sieved to obtain granules with diameter ranging between 0.2 and 1.0 mm. The final composition of the granules was 87 % DCPD and 17 % -TCP (Tamimi et al. 2005 ). The in vivo study was performed in a rabbit experimental model using a titanium bone conduction cylinder. The titanium cylinders (Apositos Sanitarios Aragoneses, Huesca, Spain) had an inner rough surface with dimensions: 4 mm-height, 0.5 mm thick and 9 mm diameter.
Fourteen healthy 6 month-old female New Zealand rabbits weighting between 3.9-4.4 kg were used as experimental animals in order to compare in vivo the bone augmentation capacity of Bio-Oss® with DTG (Tamimi et al. 2005) . The rabbits were divided in two groups of seven each, the first group was to be treated with Bio-Oss® (group 1) and the second group with DTG (group 2). The animals were accommodated in the official stable for animal assays of the UCM at 22-24 ºC with 55-70 % humidity, light cycles of 12 hour, and air renewal 15 times per hour. The rabbits were fed with a Panlab® (Barcelona, Spain) diet while drinking was permitted ad libitum.
Prior to beginning the "in vivo" animal study the protocol was approved by the ethical committee for animal experiments of the Complutense University of Madrid (UCM). Experiments were conducted in accordance with the guidelines laid down by the European Communities Council Directive of 24 November 1986 (86/609/EEC) and adequate measurements were taken to minimize pain and discomfort in the animals.
Surgical procedure
The rabbits were anesthetized with an intramuscular dose of 0.75 mg/kg ketamine (Imalgene 1000®, Rhone Merieux, France) and 0.25 mg/kg xilacine (Rompun®, Bayer, Leverkusen, Germany). Animals were placed in sternal recumbency, the head was shaved and the cutaneous surface was disinfected with povidone iod solution prior to the operation. The calvaria bone was exposed through a skin incision of approximately 4 cm in length over the linea media. A pair of tweezers was used to lift the skin before the periostium was also incised in the same place. A periosteal elevator was used for separating the periosteum from the bone surface. Two circular slits (10 mm diameter x 0.5 mm deep) were made in the parietal bone using a trephine on a slow-speed electric handpiece applying 0.9 % physiologic saline irrigation. The slits were made on each side of the median sagittal suture without crossing it. A titanium cylinder barrier was created by mechanically fixing the titanium cylinder on each slit applying slight pressure on it. The bone surface surrounded by the ring was slightly roughened with a rounded burr to promote bleeding ( See Fig 2. ). The tested biomaterials are stabilized inside the cylinders, and on each rabbit the right cylinder was grafted with 0.25 g of experimental biomaterial (Group 1: Bio-Oss® and Group 2: DTG) while the contralateral chamber was filled with autologous blood clot as negative control (Group 1: Control 1 and Group 2: Control 2). Closure of periosteum and subcutaneous tissues was done with resorbable Dexon®3/0 sutures (North Haven, Connecticut, USA), while F o r P e e r R e v i e w the skin was relocated with (3/0) silk continuous sutures (Apositos Sanitarios Aragoneses, Huesca, Spain). Post operative antibiotics were administered, Terramicina® (Pfizer, Spain), in water for 7 days. The animals were sacrificed 4 weeks after the intervention with an overdose of sodium pentobarbital IV (Dolethal®; Vetoquinol, Lure, France).
Postmortem, a surgical burr attached to a slow-speed electrical handpiece was used to harvest the bone blocks containing the titanium conduction cylinders from the animal's calvariae. Samples were then preserved fixed in formaldehyde 10 % buffer solution at pH 7.0 prior to further analysis. (Fig 2) Densitometry Postmortem bone mineral density analyses were done on the calvaria blocks using the XR-26 Norland® Densitometer (Norland Corp; Fort Atkinson, WI, USA). In each calvaria block, a bone area of 0.5 x 0.5 cm 2 was analyzed inside both the experimental (Bio-Oss and DTG) and control (Control 1 and Control 2) chambers. Exploring resolution was 1.0 x 1.0 mm 2 , measuring resolution at 0.5 x 0.5 mm 2 and exploration speed at 40 mm/s. The bone mineral content (BMC) values for the experimental and control samples were obtained from the densitometry analysis and the bone mineral density (BMD) was calculated using the formula:
where the area is always 0.25 cm 2 , BMC values are expressed in grams and BMD values in g/cm².
Histology and histomorphometry
Bone samples were dehydrated in ascending series of alcohol (60-100 %), embedded in 2-hidroxy-ethyl-methacrylate, then photopolimerized 6 hours with ultraviolet light, 2 hours with white light and 6 hours with blue light into ready-to-cut sample blocks. A saw microtome Exakt® (Norderstedt, Germany) was used to cut coronal sections form the cylinders as described elsewhere (Slotte et al. 1999 ), 200µm thick. The sections were then ground to a total thickness of 50-80 µm by means of a grinder Exakt® (Norderstedt, Germany) in order to achieve better histological visualization without risking the loss of the samples. Afterwards, surface staining was performed with hematoxylin & eosin (HE) and toluidine blue (TB) (Donath et al. 1982) . The histological evaluation of bone neoformation was carried out by means of optical F o r P e e r R e v i e w microscopy. To make the histomorphometric analysis, light micrographs (at magnification x 6) of the biopsy slices were captured with a digital camera and analyzed with the histomorphometry software MIP-4 (Digital Image System, Barcelona, Spain). Six randomly selected slices were analyzed for each biopsy. In each section, the area inside the cylinder was included for histomorphometric evaluation while the original cortical bone and the area outside the cylinder were excluded. The already existing bone was lamellar while the regenerated bone was woven and grew inside the cylinder so both types of bone could be easily differentiated in the histological observations.
The following measurements were taken from each cylinder: total sample volume, newly formed bone, and remaining graft volume. These data permit to calculate the following parameters: average augmented bone volume formed in the cylinder (BV), volume of the remaining graft material (RG) and augmented mineralized tissue (AMT).
Newly formed bone volume BV (%) = total sample volume x 100
Remaining graft volume RG (%) = total sample volume x 100 AMT = BV+RG
Statistical analysis
A statistical software package (SPSS 7.0 Chicago, IL) was used for analyzing the histomorphometric and densitometry measurements by the Mann-Whitney test. Significance for the analysis was set at p<0.05.
Results
There were no surgical complications during the preparation of the bone conduction cylinder and its filling with the experimental biomaterials. After the intervention the animals recovered without post operative signs of infection and no animals were lost during the study.
Densitometry
As shown in Table 1 , the chambers grafted with BioOss® and with DTG had similar BMD values, which are significantly higher than those of the ungrafted negative controls (control 1 and 2).
( 
Histology
The histological observation of the slices taken from the different groups of bone conduction cylinders showed no inflammatory reaction. In the ungrafted chambers (control 1 and control 2) scarce bone formation activity was observed and only a few short and isolated trabeculae could be distinguished on the external surface of the cortical (Fig. 3) . Neither osteoblasts nor osteoclasts were found in both control chambers.
In the chambers grafted with Bio-Oss® (Figs 4 and 5) , implanted granules were observed distributed over the whole specimen area. Bio-Oss® was dyed red by HE and greyish with TB. Bio-Oss® particles presented lacunae free from osteocytes due to their animal origin, nevertheless their artificial shape differentiate them from the bone trabecula growing around. Bio-Oss® granules were mostly surrounded by a thin layer of fibrous tissue at the medium and upper tiers, and by bone trabeculae at the lower tier (corresponding to the area in contact with the calvaria). Bone regeneration was observed from the external surface of the cortical to approximately 1/3 of the height of the cylinder. However, signs of biomaterial resorption such as osteoclasts forming Howship's lacunae on its surface, etching, pits or resorptive trail formation could not be identified on Bio-Oss® granules. From this observation we infer that 4 weeks after implantation in rabbits' calvariae Bio-Oss® showed osteoconductive properties but resorption did not took place.
In the cylinders grafted with DTG (Figs 6, 7, 8 and 9), the remaining granules were observed over the whole specimen area. DTG granules were intensely dark brown dyed by HE, while with TB the granules had a light grey colour. DTG particles presented a rounded morphology invaded by neoformed bone trabeculae growing from the external surface of the parietal bone, especially at the lower and medium tiers of the cylinder, and no inflammatory foreign body reaction was observed. Moreover, the surface of the biomaterial showed signs of resorption such as multinucleated cells forming Howship's lacunae, surface pitting, resorption trail formation, and remaining granules being perforated by the new bone (see Fig. 6 ). This material can be considered osteoconductive and bioresorblable.
( The data obtained from histomorphometry analysis are shown on Table 2 . The BV values are significantly higher for DTG grafted cylinders followed by Bio-Oss® cylinders and the negative controls. The RG values revealed that the chambers filled with Bio-Oss® presented less graft resorption than those filled with DTG. AMT values were similar for both Bio-Oss® and DTG cylinders while negative controls had lower AMT. (Table 2) 
DISCUSSION
Several authors consider that a four week period of implantation is enough time to observe angiogenesis and bone formation in several animal models, including rabbits, were experimental biomaterials are grafted into bone defects (Herron et al. 2003 , Schmid et al. 1997 , Boo et al. 2002 . In our experiment the histological changes that occurred in the grafted areas during the four weeks of implantation were pronounced and permit to evaluate the differences in bone regeneration capacity of both assayed biomaterials.
BMD values of the Bio-Oss® and DTG grafted cylinders were similar but significantly higher than the BMD values of the negative controls. Even though the densitometry analysis could be biased by the remaining unresorbed granules, the histomorphometric study revealed that in the control groups no regenerated bone is formed. By contrast, both the Bio-Oss® and DTG groups offered significantly higher neoformed bone percentages.
In this study there was no need to use histological apposition markers for identifying the newly formed bone because with the titanium cylinder model, the edges of the bone defect were clearly limited by the walls of the titanium cylinder (Slotte et al. 2003) . On the other hand, the critical size defect model presents problems in identifying the original edges of the defects and apposition markers, such as tetracycline, are needed for recognizing the newly formed bone (Pautke et al. 2005) .
The BV values obtained in samples treated with Bio-Oss® were comparable to that found in the literature (Slotte et al. 1999) where Bio-Oss® was grafted into silicone F o r P e e r R e v i e w cylinders on rats' calvariae (18.1 %) or in titanium cylinders on rabbits' calvariae (19.9 %) (Slotte et al. 2003) . Nevertheless, the BV value obtained with the DTG granules was significantly higher than that achieved with Bio-Oss®. Since the use of Bio-Oss® is widely spread in oral surgery, the result obtained with the DTG granules seems promising and worth to continue investigating (Tamimi et al. 2005) .
Bio-Oss® is considered a non resorbable material because it needs several years (3-6 years) of implantation before showing some slow in vivo resorption through osteoclast activity (Taylor et al. 2002) . The presence of unresorbed granules within the newly formed bone is undesired because it interferes with new bone growth and compromises the properties of the resulting tissue affecting its osteintegration capacity for dental implants (Zaffe et al. 2005 , Duda et al. 2004 , De Boever et al. 2005 , Stavropoulos et al. 2004 ). Other authors claim that biomaterials with slow in vivo resorption can interfere bone growth instead of enhancing it, however, we couldn't see this effect in our study because the ungrafted negative control samples had always much less bone augmentation than the samples grafted with the experimental biomaterial (Stavropoulos et al. 2004 ).
In our study Bio-Oss® showed no signs of graft resorption, and the biomaterial still occupied the whole area of the cylinder 4 weeks after the intervention. On the other hand, DTG implanted granules were heavily penetrated by the newly formed bone through pitting and resorption trails confirming its bioresorption properties. This observation was supported by the RG values which were significantly lower for the DTG grafted granules.
We attribute the high bioresorption of DTG to the presence of DCPD and -TCP in its composition. -TCP is moderately resorbable in vivo and needs only 12 weeks to be totally resorbed from bone defects created in animal models such as dogs, and 6 to 8 months when implanted in humans (Suba et al. 2004 , Wiltfang et al. 2003 . Furthermore, DCPD can be resorbed in vivo even faster than -TCP because it is more soluble in water (Tas et al. 2004 , Chow et al 2003 , Herron et al. 2003 . The combination of these two materials in form of granules permits the diffusion of the ioninc species as well as the nutrients that would enhance the resorption of the material and the formation of new bone tissue. Bone growth was observed in the interior of our novel biomaterial inside the spaces where brushite resorption had already taken place; DTG appeared to be drilled by new bone formation while in the Bio-Oss® grafts, bone formation took place only around the granules.
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